Entera Bio (NASDAQ:ENTX) reported its Q2 earnings results on Thursday, August 11, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Entera Bio beat estimated earnings by 31.25%, reporting an EPS of $-0.11 versus an estimate of $-0.16.
Revenue was down $65 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 2.87% increase in the share price the next day.
Here's a look at Entera Bio's past performance:
To track all earnings releases for Entera Bio visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
